Healthcare & Life Sciences
Aulos Bioscience
series-a
series-a
Stage
1
Investors
About
Aulos Bioscience is a clinical-stage biotechnology company developing imneskibart, a therapeutic candidate for cancer, with reported Phase 1/2 and Phase 2 clinical data in melanoma and non-small cell lung cancer.
Explore Aulos Bioscience's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.